NAUTILUS BIOTECHNOLOGY INC's ticker is and the CUSIP is 63909J908. A total of 3 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,660 | +1480.0% | 13,500 | +800.0% | 0.00% | – |
| Q4 2022 | $2,700 | -32.5% | 1,500 | -25.0% | 0.00% | – |
| Q3 2022 | $4,000 | -60.0% | 2,000 | -44.4% | 0.00% | – |
| Q2 2022 | $10,000 | -97.0% | 3,600 | -95.3% | 0.00% | – |
| Q1 2022 | $332,000 | -78.5% | 76,400 | -74.4% | 0.00% | -100.0% |
| Q4 2021 | $1,546,000 | +166.6% | 298,400 | +216.1% | 0.00% | 0.0% |
| Q3 2021 | $580,000 | – | 94,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,500 | $42,660 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |